MRNA — Recent News Coverage
All news mentioning MRNA in ESEN's AI-graded feed
News stories with MRNA as an affected ticker. Each article is graded by ESEN AI for impact level and direction (up/down/flat) on MRNA. See /coverage/MRNA for the 30-day aggregate.
SEEKINGALPHA.COM
·
2026-08-10
LOW
NEUTRAL
CORR0.35
Moderna: I'm Still On The Sidelines, But Here's What Would Change My Mind (NASDAQ:MRNA)
$MRNA
◈ ESEN AI
Moderna (MRNA) faces a mixed narrative with both catalysts and headwinds creating valuation uncertainty. The company secured an FDA win for mFLUSIVA, representing a meaningful pipeline milestone in the respiratory vacci…
MANILATIMES.NET
·
2026-08-06
LOW
NEUTRAL
CORR0.15
CytomX Therapeutics Announces Q2 2026 Financial Results and Provides Business Update
$CTMX
$AMGN
$MRNA
◈ ESEN AI
CytomX Therapeutics (CTMX) released Q2 2026 financial results alongside a business update centered on its Varseta-M program, a clinical-stage therapeutic candidate. This represents routine earnings disclosure and progra…
SEEKINGALPHA.COM
·
2026-08-06
NEUTRAL
BEARISH
CORR0.42
The Rise And Fall Of Situational Awareness
$GOOGL
$MRNA
◈ ESEN AI
A significant AI hedge fund meltdown has triggered renewed volatility across technology equities, raising questions about the sustainability of algorithmic trading strategies and concentrated sector bets. The incident u…
SEEKINGALPHA.COM
·
2026-08-06
NEUTRAL
NEUTRAL
CORR0.35
Moderna, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:MRNA) 2026-08-06
$MRNA
◈ ESEN AI
Moderna released its 2026 Q2 earnings presentation on August 6, providing shareholders and market participants with quarterly financial and operational updates. Earnings call presentations serve as formal documentation …
SEEKINGALPHA.COM
·
2026-07-31
NEUTRAL
BULLISH
CORR0.35
Moderna reiterates up to 10% 2026 revenue growth while lowering cash cost guidance to ~$4B (NASDAQ:MRNA)
$MRNA
◈ ESEN AI
Moderna issued forward guidance indicating up to 10% revenue growth for 2026 while simultaneously reducing cash cost guidance to approximately $4 billion annually. This dual messaging reflects management's confidence in…
SEEKINGALPHA.COM
·
2026-07-31
NEUTRAL
NEUTRAL
CORR0.35
Moderna, Inc. (MRNA) Q2 2026 Earnings Call Transcript
$MRNA
◈ ESEN AI
Moderna (MRNA) released its Q2 2026 earnings call transcript on July 31, 2026. The submission of an earnings call transcript is a routine disclosure event rather than a market-catalyzing announcement. Without access to …
SEEKINGALPHA.COM
·
2026-07-31
NEUTRAL
NEUTRAL
CORR0.15
Moderna Q2: Weak Revenue, Strong Pipeline - Here's What Matters Now (NASDAQ:MRNA)
$MRNA
◈ ESEN AI
Moderna (MRNA) faces a critical inflection point as post-COVID revenue normalization pressures near-term earnings while management signals strategic pivot toward diversified pipeline development. The Q2 weakness reflect…
FINANCE.YAHOO.COM
·
2026-07-29
HIGH
BULLISH
CORR0.72
Moderna Stock Has Doubled in 2026, But Wall Street Still Isn’t Convinced
$MRNA
◈ ESEN AI
MRNA has doubled year-to-date in 2026, signaling renewed investor confidence in the biotech sector despite Wall Street's measured stance. This performance reflects a broader sector recovery driven by accelerating capita…
SEEKINGALPHA.COM
·
2026-07-13
NEUTRAL
BULLISH
CORR0.42
Arbutus Biopharma: Moderna Validates My IP Bull Case (NASDAQ:ABUS)
$ABUS
$MRNA
◈ ESEN AI
Arbutus Biopharma (ABUS) is gaining market credibility through Moderna's validation of its lipid nanoparticle (LNP) patent portfolio. This third-party endorsement strengthens Arbutus's intellectual property position, re…
INSIDERMONKEY.COM
·
2026-07-08
LOW
BULLISH
CORR0.72
10 Best Performing American Stocks in June 2026
$MRNA
$BFLY
◈ ESEN AI
This article catalogs the top-performing equities in June 2026, anchored by Fidelity's assertion that market breadth remains robust. The observation that corporate earnings growth continues to underpin stock valuations …
FINANCE.YAHOO.COM
·
2026-07-07
NEUTRAL
BULLISH
CORR0.42
Moderna Stock Is Soaring. Is It Too Late to Buy?
$MRNA
◈ ESEN AI
MRNA is experiencing upward momentum, with market commentary framing its trajectory as the beginning of a sustained growth cycle rather than a cyclical rally. The phrasing suggests investor confidence in the company's p…
FINANCE.YAHOO.COM
·
2026-07-04
NEUTRAL
BULLISH
CORR0.42
Jim Cramer Says “For the First Time in Ages, I Like Having a Position in Moderna”
$MRNA
◈ ESEN AI
Moderna (MRNA) has attracted renewed attention from market commentator Jim Cramer, who signaled a positive tactical stance on the biotech stock amid broader market rotation dynamics. Cramer's endorsement underscores a s…
SEEKINGALPHA.COM
·
2026-07-04
NEUTRAL
BULLISH
CORR0.72
What Moved Markets This Week
$WDC
$STX
$ON
$MRNA
◈ ESEN AI
U.S. equities closed a holiday-shortened week in positive territory as participants demonstrated selective risk appetite despite underlying labor market deterioration. The week's performance suggests a bifurcated market…
FINANCE.YAHOO.COM
·
2026-07-03
NEUTRAL
NEUTRAL
CORR0.35
Moderna vs. Recursion: Which Cutting-Edge Pharma Stock Is a Better Buy in 2026?
$MRNA
$RXRX
◈ ESEN AI
Moderna (MRNA) and Recursion (RXRX) represent divergent approaches to pharmaceutical innovation, with the former leveraging established mRNA platform expansion into oncology and personalized medicine, while the latter p…
INVESTORIDEAS.COM
·
2026-06-26
HIGH
BULLISH
CORR0.72
Biotech's Rapid Response to the 2026 Ebola Outbreak: Vaccines, Antibodies, and Therapeutics Advance
$SNGX
$AEMD
$REGN
$MRNA
◈ ESEN AI
A global Ebola outbreak in 2026 has triggered accelerated development across the biotech sector, with specialized players SNGX, AEMD, REGN, and MRNA mobilizing vaccine, antibody, and therapeutic platforms against Bundib…
SEEKINGALPHA.COM
·
2026-06-26
NEUTRAL
BULLISH
CORR0.42
Moderna, Inc. (MRNA) Discusses Advancements in mRNA Technology, Clinical Modalities, and Future Horizons in Science Transcript
$MRNA
◈ ESEN AI
Moderna (MRNA) has disclosed advancements in its core mRNA platform technology and expanded clinical development efforts across multiple therapeutic modalities. The company's discussion of progress in both vaccine and n…
SEEKINGALPHA.COM
·
2026-06-24
NEUTRAL
BULLISH
CORR0.42
Moderna: Flu Vaccine Progress Is Only Part Of The Story (NASDAQ:MRNA)
$MRNA
◈ ESEN AI
Moderna secured unanimous advisory committee backing for its mRNA-1010 flu vaccine candidate targeting adults aged 50 and older, signaling regulatory momentum in the competitive seasonal influenza immunization market. T…
SEEKINGALPHA.COM
·
2026-06-23
NEUTRAL
BEARISH
CORR0.15
Moderna: From Buy To Sell After 128.2% Surge (Rating Downgrade) (NASDAQ:MRNA)
$MRNA
◈ ESEN AI
Moderna (MRNA) has triggered a downgrade from Buy to Sell following a substantial 128.2% rally, suggesting the stock has repriced significantly ahead of fundamentals. The upgrade reflects valuation concerns rather than …
SEEKINGALPHA.COM
·
2026-06-23
NEUTRAL
BULLISH
CORR0.42
Moderna: The Comeback Is Now In Full Swing (NASDAQ:MRNA)
$MRNA
◈ ESEN AI
Moderna (MRNA) is executing a strategic pivot away from pandemic-dependent COVID revenue toward a diversified mRNA platform. The company's transition to endemic vaccines like mFlusiva and combination shot development si…
SEEKINGALPHA.COM
·
2026-06-21
NEUTRAL
NEUTRAL
CORR0.15
Notable healthcare headlines for the week: Merck, Moderna, and Biogen in focus
$MRNA
$MRK
$JNJ
$BIIB
$LLY
◈ ESEN AI
Healthcare equities displayed divergent momentum this week as Moderna (MRNA) rallied while the broader Health Care Select Sector ETF (XLV) declined. The sector's mixed performance reflects competing macro and regulatory…
BENZINGA.COM
·
2026-06-17
LOW
NEUTRAL
CORR0.45
NFLX, SOFI, SNAP, MRNA,OBAI: 5 Trending Stocks Today - Netflix (NASDAQ:NFLX)
$NFLX
$SOFI
$SNAP
$MRNA
◈ ESEN AI
This article flags five stocks as trending without substantive catalyst disclosure, making it a routine trend-scan piece rather than fundamental analysis. The headline-driven format suggests retail interest monitoring r…
EXPLORE OTHER FILTERS